Statement of Financial Position Statement (USD $) In Thousands	Sep. 30, 2011	Dec. 31, 2010
Cash and Cash Equivalents, at Carrying Value	$ 17,021	$ 133,880
Accounts Receivable, Net	157,594	154,726
Inventory, Net	52,536	33,979
Prepaid Expense and Other Assets	27,272	26,735
TOTAL CURRENT ASSETS	254,423	349,320
Property, Plant and Equipment, Net	110,025	104,223
Intangible Assets, Net (Excluding Goodwill)	7,969	8,660
Goodwill	162,326	154,217
Deferred Tax Assets, Net, Noncurrent	6,586	0
Other Assets, Noncurrent	21,572	19,622
TOTAL ASSETS	562,901	636,042
Accounts Payable, Current	46,776	44,710
Employee-related Liabilities, Current	30,470	28,621
Sales and Excise Tax Payable, Current	7,656	7,796
Deferred Revenue, Current	18,912	20,181
Taxes Payable, Current	10,250	21,004
Convertible Debt, Current	84,493	147,543
Other Accrued Liabilities, Current	11,562	9,498
TOTAL CURRENT LIABILITIES	210,119	279,353
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	155,093	0
Deferred Compensation Liability, Classified, Noncurrent	22,307	21,241
Deferred Tax Liabilities, Noncurrent	0	2,198
Other Liabilities, Noncurrent	36,823	32,046
Temporary Equity, Redemption Value	509	8,864
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1,376	1,397
Additional Paid in Capital, Common Stock	0	0
Retained Earnings (Accumulated Deficit)	296,172	536,991
Accumulated Other Comprehensive Income (Loss), Net of Tax	(5,979)	(6,207)
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010	(157,187)	(242,690)
Total Core Laboratories N.V. shareholders' equity	134,382	289,491
Stockholders' Equity Attributable to Noncontrolling Interest	3,668	2,849
TOTAL EQUITY	138,050	292,340
TOTAL LIABILITIES AND EQUITY	$ 562,901	$ 636,042